A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.


Updates from The Motley Fool

Latest updates on Corcept Therapeutics from Fool.com.


Stock Performance

CORT vs. S&P 500 | 2 Year Performance
View Interactive CORT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Corcept Therapeutics.
Current Price: $5.45
Prev Close: $5.50
Open: $5.50
Bid: $5.40
Ask: $6.10
Day's Range: $5.41 - $5.65
52wk Range: $3.22 - $6.33
Volume: 132,895
Avg Vol 271,292
Market Cap: $592.83M
P/E (ttm): 550.00
EPS (ttm): $0.01
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Corcept Therapeutics.
CAPS Rating 1 out of 5
 
77 Outperform
31 Underperform
CAPS All Stars
 
11 Outperform
11 Underperform

How do you think Corcept Therapeutics will perform against the market?



You pick for Corcept Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph K. Belanoff, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Corcept Therapeutics.

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers